Drug delivery solutions
We are committed to investing in the next generation of excipients you need. Our teams work with you to troubleshoot formulations and develop research grade and GMP excipient solutions. Purity is our forte across our multi-compendial, GMP grade materials.
Explore by platform
We are a world leader of pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications. Explore our drug delivery platforms to learn more. We have a vast product offering available across each of our drug delivery platforms for human and veterinary applications, including Small Molecule Delivery, Protein Delivery, Nucleic Acid Delivery, Adjuvant Systems and Consumer Health.
Explore by product
We offer an extensive product offering to meet the needs for our customers. With an ever increasing list of high purity specialty ingredients, we are proud to be your partner in bringing drug products to market. Alongside our product range, we have extensive expertise in working with our products in their various applications, and actively work with customers to solve any issues they are facing, whether it be stabilising a difficult drug, delivering the drug to its intended site of action, or prolonging drug product shelf life through the use of high purity ingredients.
Explore by market
Our purpose, Smart science to improve lives™, is at the core of our human and veterinary market strategy. We support the pharmaceutical market by developing high purity excipients which enhance delivery, efficacy, and stability of actives. We also manufacture industry leading high purity vaccine adjuvants and innovative lipids.
Explore new products
Explore our newest range of products available across our technology platforms.
Explore recent blogs:
New Research Professor MSO in Vaccine Adjuvants at Statens Serum Institut Copenhagen, Denmark
PRESS RELEASE: Croda Pharma is happy to announce that Dennis Christensen, PhD, Head of Global Research and Development for Vaccine Adjuvant Systems, has been appointed as a part-time Research...
Croda Pharma launches a new bioprocessing solution for shear stress in mammalian cell culture
Croda Pharma has announced the launch of Super Refined™ Poloxamer 188, an innovative bioprocessing solution developed to meet the increasing demands of biopharmaceutical development.